Results 141 to 150 of about 4,707 (174)
Some of the next articles are maybe not open access.

Cost-effectiveness of tenecteplase versus alteplase for acute ischemic stroke [PDF]

open access: yesEuropean Stroke Journal, 2023
INTRODUCTION: Alteplase is widely used as an intravenous thrombolytic drug in acute ischemic stroke (AIS). Recently however, tenecteplase, a modified form of tissue plasminogen activator, has been shown to increase early recanalization rate and has ...
Yvo Roos   +2 more
exaly   +2 more sources

Tenecteplase: a review

Clinical Therapeutics, 2001
Certain shortcomings of the available thrombolytic agents have prompted the search for a more fibrin specific fibrinolytic agent with a longer half-life. Such properties would allow bolus administration, possibly leading to faster reperfusion of occluded arteries.This article focuses on the new thrombolytic agent tenecteplase, reviewing its mechanism ...
L, Davydov, J W, Cheng
openaire   +2 more sources

Tenecteplase

Hospital Pharmacy, 2000
Each month, subscribers to The Formulary® Monograph Service receive five to six researched monographs on drugs that are newly released or are in late Phase III trials. The monographs are targeted to your Pharmacy and Therapeutics Committee. Subscribers also receive monthly one-page summary monographs on the agents that are useful for agendas and ...
Dennis J. Cada   +2 more
openaire   +1 more source

Tenecteplase

Reactions Weekly, 2021
openaire   +2 more sources

Home - About - Disclaimer - Privacy